About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Phosphatidylcholine Supplementation in Infants

Phosphatidylcholine Supplementation in Infants

NCT01905605·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University of Colorado, Denver

Age

0–0

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Healthy infant has an age (adjusted for gestational age at birth) of 1-7 weeks
Diminished P50 sensory gating (ratio greater than or equal to 0.50)

You may not be if

No maternal reported tobacco use for greater than 1 year and no current tobacco use (as measured by urine cotinine levels)
Trimethylaminuria, renal disease, liver disease, known chromosomal abnormality, chronic neurological disorder, premature birth, prenatal exposure to exogenous steroid use

The record

StatusWithdrawn

PhasePhase 1–2

Taking part0

StartedSep 2013

UpdatedSep 2, 2020

Conditions

Schizophrenia Diminished P50 Sensory Gating

Where1

University of Colorado Denver
Aurora, Colorado, United States